BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$465M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$329M |
| 3 |
Procter & Gamble
PG
|
+$261M |
| 4 |
iShares Russell 2000 Growth ETF
IWO
|
+$238M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$227M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$830M |
| 2 |
SPDR Gold Trust
GLD
|
+$563M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$195M |
| 4 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$171M |
| 5 |
Alibaba
BABA
|
+$159M |
Sector Composition
| 1 | Technology | 10.15% |
| 2 | Financials | 8.84% |
| 3 | Communication Services | 8.44% |
| 4 | Consumer Discretionary | 6.71% |
| 5 | Healthcare | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATHX
3126
DELISTED
Athersys, Inc. Common Stock
ATHX
| $9.62K | ﹤0.01% |
181
+61
| +51% | +$3.24K |
|
|
LSBG
3127
DELISTED
Lake Sunapee Bank Group
LSBG
| $9.61K | ﹤0.01% |
532
+222
| +72% | +$4.01K |
|
3128
Oppenheimer Holdings
OPY
$763M
| $9.6K | ﹤0.01% |
672
+281
| +72% | +$4.02K |
|
3129
Ryerson Holding
RYI
$708M
| $9.57K | ﹤0.01% |
848
+421
| +99% | +$4.75K |
|
3130
National Research Corp
NRC
$365M
| $9.56K | ﹤0.01% |
587
+301
| +105% | +$4.9K |
|
3131
Tandem Diabetes Care
TNDM
$834M
| $9.56K | ﹤0.01% |
125
+53
| +74% | +$4.05K |
|
|
VIA
3132
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $9.56K | ﹤0.01% |
131
+55
| +72% | +$4.01K |
|
3133
Voyager Therapeutics
VYGR
$234M
| $9.55K | ﹤0.01% |
795
+229
| +40% | +$2.75K |
|
|
CRCM
3134
DELISTED
CARE.COM, INC.
CRCM
| $9.51K | ﹤0.01% |
955
+326
| +52% | +$3.25K |
|
3135
Intellia Therapeutics
NTLA
$1.21B
| $9.5K | ﹤0.01% |
558
+282
| +102% | +$4.8K |
|
3136
IES Holdings
IESC
$7.56B
| $9.46K | ﹤0.01% |
532
+222
| +72% | +$3.95K |
|
|
CWBC
3137
Community West Bancshares
CWBC
$403M
| $9.44K | ﹤0.01% |
595
+249
| +72% | +$3.95K |
|
|
TTPH
3138
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $9.4K | ﹤0.01% |
123
+52
| +73% | +$3.97K |
|
|
CCXI
3139
DELISTED
ChemoCentryx, Inc.
CCXI
| $9.4K | ﹤0.01% |
1,556
+715
| +85% | +$4.32K |
|
3140
Build-A-Bear
BBW
$975M
| $9.39K | ﹤0.01% |
906
+385
| +74% | +$3.99K |
|
|
ENTL
3141
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $9.38K | ﹤0.01% |
423
+134
| +46% | +$2.97K |
|
|
MOBL
3142
DELISTED
MobileIron, Inc.
MOBL
| $9.37K | ﹤0.01% |
3,406
+1,601
| +89% | +$4.4K |
|
3143
Talphera
TLPH
$17M
| $9.36K | ﹤0.01% |
120
+50
| +71% | +$3.9K |
|
|
CUTR
3144
DELISTED
Cutera, Inc.
CUTR
| $9.36K | ﹤0.01% |
785
+333
| +74% | +$3.97K |
|
|
JMBA
3145
DELISTED
Jamba, Inc.
JMBA
| $9.34K | ﹤0.01% |
855
+362
| +73% | +$3.95K |
|
|
GIG
3146
DELISTED
GigPeak, Inc.
GIG
| $9.25K | ﹤0.01% |
3,935
+2,099
| +114% | +$4.93K |
|
3147
Rush Enterprises Class B
RUSHB
$4.39B
| $9.24K | ﹤0.01% |
855
+268
| +46% | +$2.9K |
|
3148
Nature's Sunshine
NATR
$301M
| $9.23K | ﹤0.01% |
577
+242
| +72% | +$3.87K |
|
|
NWHM
3149
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $9.21K | ﹤0.01% |
863
+361
| +72% | +$3.85K |
|
3150
Donegal Group Class A
DGICA
$695M
| $9.17K | ﹤0.01% |
569
+236
| +71% | +$3.8K |
|